SARDAPHARMA
Board
1 director, no change since 2024Director (not named in the articles)
since 01-01-2010
term without a fixed end
earlier manager, until 18-06-2024
listed in the 2023 annual accounts, filed on 06-11-2024
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Manager
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager, from 01-01-2010 to 18-06-2024
- Director (not named in the articles), appointed by deed of 18-06-2024, still in office
-
- Manager, until 03-08-2012
Control
Capital
- Contribution
- €18,592.01
- Source
- 2024 annual accounts
Articles of association
deed of 18-06-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Moitié cédant,moitié acquéreurs au prorata si plusieurs, commun accord ou président du tribunal de l'entreprise statuant comme en référé à requête partie dilige…
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of May at 19:00
Capital transactions
Capital over time
- 18-06-2024 Converted to unavailable equity
- 18-06-2024 Converted to available equity